A Phase 1B Study with Trail-R1 Antibody Mapatumumab in Combination with Cisplatin and Radiotherapy (Rt) As First Line Therapy in Patients (Pts) with Advanced Cervical Cancer Abstract Withdrawn. - Withdrawal Notice | RetractBase